Company Filing History:
5 out of 14 
4 out of 60 
1 out of 80 
Years Active: 2006-2015
Title: Ann-Kristin Mueller: Innovator in Malaria Vaccine Development
Introduction
Ann-Kristin Mueller is a prominent inventor based in Dossenheim, Germany. She has made significant contributions to the field of malaria vaccine research, holding a total of six patents. Her work focuses on innovative approaches to combat malaria, a disease that continues to pose a global health challenge.
Latest Patents
Among her latest patents is a groundbreaking invention related to malaria vaccines based on apicomplexan ferlins, ferlin-like proteins, and other C2-domain containing proteins. This invention involves peptides that comprise at least one antigenic determinant or epitope of an apicomplexan Ferlin, Ferlin-like protein, and/or another C2-domain containing protein for use as malaria vaccines. Additionally, she has developed a method for inoculating a vertebrate host against malaria using a live genetically attenuated malaria vaccine. This method involves administering a live organism that is genetically engineered to disrupt a liver-stage-specific gene function.
Career Highlights
Throughout her career, Ann-Kristin Mueller has worked with esteemed organizations such as the Seattle Biomedical Research Institute and Ruprecht-Karls-Universität Heidelberg. Her research has been pivotal in advancing the understanding and development of malaria vaccines.
Collaborations
She has collaborated with notable colleagues in her field, including Stefan H. I. Kappe and Kai-Uwe C. Matuschewski. These collaborations have further enriched her research and contributed to the progress in malaria vaccine development.
Conclusion
Ann-Kristin Mueller's innovative work in malaria vaccine research exemplifies her dedication to addressing global health issues. Her patents and collaborations highlight her significant impact in the field, making her a key figure in the fight against malaria.